田文杰,葛均波

• 1: 复旦大学附属中山医院心内科
• 2:复旦大学附属中山医院心内科

摘要(Abstract)：

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 田文杰,葛均波

参考文献(References)：

• [1]Noguchi T,Miyazaki MDS,Morii I,et al.Percutaneous translu-minal coronary angioplasty of chronic total occlusions:determi-nants of primary success and long-term outcome.Cathet Cardio-vasc Intervent,2000,49:258-264.
• [2]Suero JA,Marso SP,Jones PG,et al.Procedural outcomes and long-term survival among patients undergoing percutaneous coro-nary intervention of a chronic total occlusion in native coronary ar-teries:a20-year experience.J Am Coll Cardiol,2001,38:409-414.
• [3]Dzavik V,Carere RG,Mancini GB,et al.Predictors of improve-ment in left ventricular function after percutaneous revasculariza-tion of occluded coronary arteries.Am Heart J,2001,142:301-308.
• [4]Rubartelli P,Verna E,Niccoli L,et al.Coronary stent implan-tation is superior to balloon angioplasty for chronic coronary oc-clusions:six year clinical follow-up of the GISSOC trial.J Am Coll Cardiol,2003,41:1488-1492.
• [5]Tamai H,Berger PB,Tsuchikane E,et al.Frequency and time course of reocclusion and restenosis in coronary artery occlusions after balloon angioplasty versus Wiktor stent implantation:results from the Mayo-Japan Investigation for Chronic Total Occlusion(MAJIC)trial.Am Heart J,2004,147:E9.
• [6]Hoye A,Tanabe K,Lemos PA,et al.Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions.J Am Coll Cardiol,2004,43:1954-1958.
• [7]Ge L,Ioannis I,John C,et al.Immediate and mid-term out-comes of sirolimus-eluting stent implantation for chronic total oc-clusions.Eur Heart J,2005,26:1056-1062.
• [8]Nakamura S,Muthusamy TS,Bae JH,et al.Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlu-sions.Am J Cardiol,2005,95:161-166.
• [9]Suttorp MJ,Laarman GJ,Rahel BM,et al.Primary Stenting of Totally Occluded Native Coronary Arteries II(PRISON II):A Randomized Comparison of Bare Metal Stent Implantation With Sirolimus-Eluting Stent Implantation for the Treatment of Total Coronary Occlusions.Circulation,2006,114:921.
• [10]Werner GS,Krack A,Schwarz G,et al.Prevention of lesion re-currence in chronic total coronary occlusions by paclitaxel-eluting stents.J Am Coll Cardiol,2004,44:2301-2306.
• [11]Eberhard G,Giuseppe BZ,Giuseppe S,et al.Assessing the Safety and Effectiveness of Taxus in183Patients with Chronic Total Occlusions:Insights from the TRUE Study.Am J Cardiol,2005,TCTABSTRACTS/Oral.
• [12]Nakamura1S,Bae JH,Cahyadi YH,et al.Comparison of Effica-cy and Safety between Sirolimus-Eluting Stent(Cypher?)and Paclitaxel-Eluting Stent(TAXUS?)on the Outcome of Patients with Chronic Total Occlusions:Multicenter Registry in Asia.Am J Cardiol,2005,96(suppl7A):38H.
• [13]Amenzind,Edoardo,Steg,et al.Stent Thrombosis Late After Implantation of First-Generation Drug-Eluting Stents:ACause for Concern.Circulation,2007,115:1440-1455.